The study reviewed 153 patients who had surgery with the system. Fifty-eight of them reached the 12-month follow-up. Researchers measured the Oswestry Disability Indexes and the visual analog scale back and leg scores in patients, according to a Nov. 4 news release.
The mean ODI improved 36.8 points at six weeks and 46.2 points at 12 months. Mean VAS-back scores improved 54.9 points at six weeks and 58.4 points at 12 months, and VAS-leg scores improved 73.5 at six weeks and 72.3 points at 12 months.
“These results point to the potential of Tops becoming a new and exciting option for the treatment of degenerative spondylolisthesis that allows us to stabilize patients while preserving motion,” John Chi, MD, of Boston-based Harvard Medical School, said in the release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
